GLP-1 Agonists Practice Tool

Many of you have downloaded and shared our SGLT2 Inhibitors Practice Tool which has reached over 4,300 downloads! Building on this success, we are now ready to start developing a practice tool on GLP-1 receptor agonists. To ensure this practice tool meets all of your needs, we would appreciate it if you could complete the very brief survey below. In addition, if you have experience using these agents in your practice, we would be interested in interviewing you to learn more about your findings and questions that have arisen. If you are interested, please contact us at info@diabetespharmacistsnetwork.ca and use the subject line GLP-1 Agonist Practice Tool.

Question Title

* 1. What content from product monographs or clinical practice guidelines would you like to see summarized and included?

i.e. dosing, renal dosing, indications, etc.

Question Title

* 2. What practice advice or expert opinion that may not be found in the product monographs would you like to see included?

Question Title

* 3. What other questions do you and/or your patients have around the use of GLP-1 agonists?

Question Title

* 4. Is there any information that you do not want to see included?

Question Title

* 5. If you are familiar with our SGLT2 Inhibitors Practice Tool - what did you like (or not like) about the format, layout and design of this tool? What (if anything) would you like to see considered in the design of our new GLP-1 Agonist Tool?

i.e does it matter to you if the tool is kept to one page, in pdf format, etc.

Click the "Done" button to submit your responses.

T